BioIntelliSense Partners with Leukemia & Lymphoma Society to Incorporate the BioSticker™ Medical Device for Continuous Monitoring in Clinical Trials
LLS clinical trials will use the FDA-cleared BioSticker to evaluate correlation of vital signs and select symptoms to treatment BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company announced the company has entered…